Gallium-68 labeled FAP inhibitors (Ga-68-FAPI) used in PET/CT imaging appear to be a promising imaging method to differentiate inflammation from fibrosis and to guide subsequent therapy in patients with stricturing Crohn’s disease; however, further studies are warranted [102,103]. Here, FAP is linked to Crohn disease.